Business ❯ Corporate Governance ❯ Investor Relations ❯ Securities
Three plaintiff firms are urging investors to file lead-plaintiff motions by August 25, 2025, in shareholder suits alleging Hims & Hers misled the market over its terminated Novo Nordisk deal.
